Respiratory Disease Testing Market Share & Size Report, 2032

Respiratory Disease Testing Market - By Test Type (Mechanical Tests, Imaging Tests, In-vitro Diagnostic Tests ), By Application (COPD, Lung Cancer, Asthma, Tuberculosis) By End-use (Diagnostic Centers, Hospitals, Clinics) & Forecast, 2023-2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Industry coverage

1.2&nbsp;&nbsp;&nbsp; Market scope &amp; definitions

1.3&nbsp;&nbsp;&nbsp; Base estimates &amp; working

1.3.1&nbsp;&nbsp;&nbsp; Data collection

1.4&nbsp;&nbsp;&nbsp; Forecast parameters

1.5&nbsp;&nbsp;&nbsp; COVID-19 impact analysis at global level

1.6&nbsp;&nbsp;&nbsp; Data validation

1.7&nbsp;&nbsp;&nbsp; Data sources

1.7.1&nbsp;&nbsp;&nbsp; Primary

1.7.2&nbsp;&nbsp;&nbsp; Secondary

1.7.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.7.2.2&nbsp;&nbsp;&nbsp;Unpaid sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Respiratory Disease Testing industry 3600 synopsis, 2018 - 2032

2.1.1&nbsp;&nbsp;&nbsp; Business trends

2.1.2&nbsp;&nbsp;&nbsp; Test type trends

2.1.3&nbsp;&nbsp;&nbsp; Application trends

2.1.4&nbsp;&nbsp;&nbsp; End-use trends

2.1.5&nbsp;&nbsp;&nbsp; Regional trends

Chapter 3&nbsp;&nbsp;&nbsp;Respiratory Disease Testing Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry landscape, 2018 &ndash; 2032

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp;Increasing government initiatives in developed and developing countries

3.2.1.2&nbsp;&nbsp;&nbsp;Rising prevalence of chronic obstructive pulmonary disease (COPD)

3.2.1.3&nbsp;&nbsp;&nbsp;Increasing healthcare spending by public and private organizations

3.2.1.4&nbsp;&nbsp;&nbsp;Exposure to dust particles and increasing number of cigarette smokers in developing as well as underdeveloped regions

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp;High cost of respiratory disease testing devices

3.2.2.2&nbsp;&nbsp;&nbsp;Unfavorable reimbursement scenario

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.3.1&nbsp;&nbsp;&nbsp; By test type

3.3.2&nbsp;&nbsp;&nbsp; By application

3.3.3&nbsp;&nbsp;&nbsp; By end-use

3.4&nbsp;&nbsp;&nbsp; COVID-19 impact analysis

3.5&nbsp;&nbsp;&nbsp; Technological landscape

3.6&nbsp;&nbsp;&nbsp; Regulatory Landscape

3.6.1&nbsp;&nbsp;&nbsp; U.S.

3.6.2&nbsp;&nbsp;&nbsp; Europe

3.7&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.8&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2022

4.1&nbsp;&nbsp;&nbsp; Introduction

4.1.1&nbsp;&nbsp;&nbsp; Becton Dickinson &amp; Company

4.1.2&nbsp;&nbsp;&nbsp; Koninklijke Philips N.V.

4.1.3&nbsp;&nbsp;&nbsp; Abbott Laboratories

4.2&nbsp;&nbsp;&nbsp; Competitive dashboard, 2022

4.3&nbsp;&nbsp;&nbsp; Company matrix analysis, 2022

4.4&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.5&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.6&nbsp;&nbsp;&nbsp; Strategic outlook matrix

Chapter 5&nbsp;&nbsp;&nbsp;Respiratory Disease Testing Market, By Test Type

5.1&nbsp;&nbsp;&nbsp; Key segment trends

5.2&nbsp;&nbsp;&nbsp; Mechanical tests

5.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

5.2.2&nbsp;&nbsp;&nbsp; Spirometry

5.2.2.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

5.2.3&nbsp;&nbsp;&nbsp; Peak-flow test

5.2.3.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

5.2.4&nbsp;&nbsp;&nbsp; Pulmonary function test

5.2.4.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

5.2.5&nbsp;&nbsp;&nbsp; Blood gas test

5.2.5.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

5.2.6&nbsp;&nbsp;&nbsp; Others

5.2.6.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

5.3&nbsp;&nbsp;&nbsp; Imaging tests

5.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

5.3.2&nbsp;&nbsp;&nbsp; X-ray

5.3.2.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

5.3.3&nbsp;&nbsp;&nbsp; CT-scan

5.3.3.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

5.3.4&nbsp;&nbsp;&nbsp; Ultrasonography

5.3.4.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

5.3.5&nbsp;&nbsp;&nbsp; MRI

5.3.5.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

5.4&nbsp;&nbsp;&nbsp; In-vitro diagnostic tests

5.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

5.4.2&nbsp;&nbsp;&nbsp; Point-of-care test

5.4.2.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

5.4.3&nbsp;&nbsp;&nbsp; Molecular diagnostic test

5.4.3.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

5.4.4&nbsp;&nbsp;&nbsp; Others

5.4.4.1&nbsp;&nbsp;&nbsp;Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6&nbsp;&nbsp;&nbsp;Respiratory Disease Testing Market, By Application

6.1&nbsp;&nbsp;&nbsp; Key segment trends

6.2&nbsp;&nbsp;&nbsp; Chronic obstructive pulmonary disease

6.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.3&nbsp;&nbsp;&nbsp; Lung cancer

6.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.4&nbsp;&nbsp;&nbsp; Asthma

6.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.5&nbsp;&nbsp;&nbsp; Tuberculosis

6.5.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

6.6&nbsp;&nbsp;&nbsp; Others

6.6.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7&nbsp;&nbsp;&nbsp;Respiratory Disease Testing Market, By End-use

7.1&nbsp;&nbsp;&nbsp; Key segment trends

7.2&nbsp;&nbsp;&nbsp; Diagnostic centers

7.2.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

7.3&nbsp;&nbsp;&nbsp; Hospitals

7.3.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

7.4&nbsp;&nbsp;&nbsp; Clinics

7.4.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

7.5&nbsp;&nbsp;&nbsp; Others

7.5.1&nbsp;&nbsp;&nbsp; Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8&nbsp;&nbsp;&nbsp;Respiratory Disease Testing Market, By Region

8.1&nbsp;&nbsp;&nbsp; Key regional trends

8.2&nbsp;&nbsp;&nbsp; North America

8.2.1&nbsp;&nbsp;&nbsp; U.S.

8.2.2&nbsp;&nbsp;&nbsp; Canada

8.3&nbsp;&nbsp;&nbsp; Europe

8.3.1&nbsp;&nbsp;&nbsp; Germany

8.3.2&nbsp;&nbsp;&nbsp; UK

8.3.3&nbsp;&nbsp;&nbsp; France

8.3.4&nbsp;&nbsp;&nbsp; Spain

8.3.5&nbsp;&nbsp;&nbsp; Italy

8.3.6&nbsp;&nbsp;&nbsp; Switzerland

8.3.7&nbsp;&nbsp;&nbsp; Sweden

8.3.8&nbsp;&nbsp;&nbsp; Poland

8.4&nbsp;&nbsp;&nbsp; Asia Pacific

8.4.1&nbsp;&nbsp;&nbsp; China

8.4.2&nbsp;&nbsp;&nbsp; Japan

8.4.3&nbsp;&nbsp;&nbsp; India

8.4.4&nbsp;&nbsp;&nbsp; Australia

8.4.5&nbsp;&nbsp;&nbsp; South Korea

8.4.6&nbsp;&nbsp;&nbsp; Indonesia

8.4.7&nbsp;&nbsp;&nbsp; Thailand

8.5&nbsp;&nbsp;&nbsp; Latin America

8.5.1&nbsp;&nbsp;&nbsp; Brazil

8.5.2&nbsp;&nbsp;&nbsp; Mexico

8.5.3&nbsp;&nbsp;&nbsp; Argentina

8.5.4&nbsp;&nbsp;&nbsp; Colombia

8.5.5&nbsp;&nbsp;&nbsp; Chile

8.5.6&nbsp;&nbsp;&nbsp; Peru

8.6&nbsp;&nbsp;&nbsp; Middle East &amp; Africa

8.6.1&nbsp;&nbsp;&nbsp; South Africa

8.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

8.6.3&nbsp;&nbsp;&nbsp; UAE

8.6.4&nbsp;&nbsp;&nbsp; Turkey

8.6.5&nbsp;&nbsp;&nbsp; Egypt

8.6.6&nbsp;&nbsp;&nbsp; Israel

8.6.7&nbsp;&nbsp;&nbsp; Qatar

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles

9.1&nbsp;&nbsp;&nbsp; Becton Dickinson &amp; Company

9.2&nbsp;&nbsp;&nbsp; VYAIRE MEDICAL, INC

9.3&nbsp;&nbsp;&nbsp; Koninklijke Philips N.V.

9.4&nbsp;&nbsp;&nbsp; ResMed

9.5&nbsp;&nbsp;&nbsp; Fischer &amp; Paykel

9.6&nbsp;&nbsp;&nbsp; Medtronic

9.7&nbsp;&nbsp;&nbsp; CAREstream Medical, Ltd

9.8&nbsp;&nbsp;&nbsp; Abbott Laboratories

9.9&nbsp;&nbsp;&nbsp; Thermo Fischer Scientific Inc

9.10&nbsp;&nbsp;&nbsp; Biomerieux

9.11&nbsp;&nbsp;&nbsp; Cosmed

9.12&nbsp;&nbsp;&nbsp; Siemens Healthineers

9.13&nbsp;&nbsp;&nbsp; SDI Diagnostics

9.14&nbsp;&nbsp;&nbsp; Seegene Inc 
&nbsp;

Respiratory Disease Testing Market

Request Discount

Industries

Information

Link

Global Headquarters